Opioid Receptors on Immune Cells May Be Fibromyalgia Biomarkers, Study Says

Opioid Receptors on Immune Cells May Be Fibromyalgia Biomarkers, Study Says
Opioid receptors found on the surface of immune cells may be useful biomarkers to diagnose people with fibromyalgia, a study found. The study, “Identification of MOR-Positive B Cell as Possible Innovative Biomarker (Mu Lympho-Marker) for Chronic Pain Diagnosis in Patients with Fibromyalgia and Osteoarthritis Diseases,” was published in the International Journal of Molecular Sciences. Fibromyalgia can be difficult to diagnose, as symptoms can be nonspecific and overlap with other medical conditions.  The identification of specific biomarkers to diagnose fibromyalgia and assess its severity and progression can help support the development of new, effective therapies.   Researchers have investigated the connection between immune cells and neurons that share common opioid receptors called Mu (MOR/Oprm1), delta (DOR/Oprd1), and kappa (KOR/Oprk1
Subscribe or to access all post and page content.